News Agency
Men's Weekly

DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY GEP-NET PATIENTS

  • Written by PR Newswire

Acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare diseases that require life-long chronic treatment. Monthly somatostatin analog (SSA) injections are the standard of care as first-line medical treatment.

Debiopharm is developing Debio 4126, a novel 3-month extended-release octreotide formulation, to...

Read more: DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR...

How Headless CMS Enhances Responsive Design and Layout Flexibility

Image by freepik As digital technology continues to evolve at a breakneck pace, users expect much more from content than ever before, and responsive design is crucial to ensure content not only looks but operates across all screens. No longer are... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion